Elizabeth J. Phillips mainly focuses on Immunology, Human leukocyte antigen, Abacavir, Internal medicine and Drug. Antigen is the focus of her Immunology research. Elizabeth J. Phillips has included themes like Major histocompatibility complex, Immune system, Allele and Drug Hypersensitivity Syndrome in her Human leukocyte antigen study.
The various areas that Elizabeth J. Phillips examines in her Abacavir study include Hypersensitivity reaction, Toxic epidermal necrolysis, CD8, Reverse-transcriptase inhibitor and Hypersensitivity syndrome. Her Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Ribavirin. Her Drug research includes themes of Pharmacogenomics and Intensive care medicine.
Her primary scientific interests are in Immunology, Human leukocyte antigen, Internal medicine, Drug and Abacavir. Her Immunology research is multidisciplinary, incorporating perspectives in Pharmacogenetics, Pharmacogenomics and Virology. Her research in Human leukocyte antigen intersects with topics in Typing, Disease, Allele and Genotype.
Her work in Internal medicine tackles topics such as Antibiotics which are related to areas like Allergy. The study incorporates disciplines such as Toxic epidermal necrolysis and Intensive care medicine in addition to Drug. Her biological study spans a wide range of topics, including Nevirapine, Hypersensitivity reaction and Genetic testing.
Elizabeth J. Phillips mostly deals with Immunology, Allergy, Intensive care medicine, Internal medicine and Drug allergy. Her study in Delayed hypersensitivity, Human leukocyte antigen, Immune system, Antigen and T cell is done as part of Immunology. Her studies in Delayed hypersensitivity integrate themes in fields like ELISPOT and Drug.
Her studies deal with areas such as Pharmacogenomics and Allele as well as Human leukocyte antigen. Her Allergy research also works with subjects such as
Elizabeth J. Phillips mainly investigates Allergy, Internal medicine, Immunology, Penicillin and T cell. Her Allergy research integrates issues from Adverse effect and Intensive care medicine. Her Internal medicine research incorporates themes from Endocrinology and T cell reactivity.
Her study in the field of Hla genotype is also linked to topics like Oxcarbazepine. Her T cell research also works with subjects such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HLA-B*5701 Screening for Hypersensitivity to Abacavir
Simon Mallal;Elizabeth Phillips;Giampiero Carosi;Jean-Michel Molina.
The New England Journal of Medicine (2008)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias.
The New England Journal of Medicine (2016)
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
Jose Mateus;Alba Grifoni;Alison Tarke;John Sidney.
Science (2020)
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Evan Phillips;Oula Penate-Medina;Pat B. Zanzonico;Richard D. Carvajal.
Science Translational Medicine (2014)
Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
Annalise M. Martin;David Nolan;Silvana Gaudieri;Silvana Gaudieri;Coral Ann Almeida.
Proceedings of the National Academy of Sciences of the United States of America (2004)
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
David Sulzer;Roy N. Alcalay;Francesca Garretti;Lucien Cote.
Nature (2017)
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
David A. Ostrov;Barry J. Grant;Yuri A. Pompeu;John Sidney.
Proceedings of the National Academy of Sciences of the United States of America (2012)
High Sensitivity of Human Leukocyte Antigen-B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients
Michael Saag;Rukmini Balu;Elizabeth Phillips;Philip Brachman.
Clinical Infectious Diseases (2008)
Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization
Andrew E. Simor;Andrew E. Simor;Elizabeth Phillips;Allison McGeer;Allison McGeer;Ana Konvalinka.
Clinical Infectious Diseases (2007)
Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts
Annalise M Martin;David Nolan;Ian James;Paul Cameron.
AIDS (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vanderbilt University Medical Center
La Jolla Institute For Allergy & Immunology
La Jolla Institute For Allergy & Immunology
Vanderbilt University Medical Center
Sunnybrook Health Science Centre
La Jolla Institute For Allergy & Immunology
Perron Institute for Neurological and Translational Science
La Jolla Institute For Allergy & Immunology
Peter MacCallum Cancer Centre
Sunnybrook Health Science Centre
Yale University
University of British Columbia
University of Manchester
LG Corporation (South Korea)
University of Porto
RWTH Aachen University
University of Hawaii at Manoa
Environment and Climate Change Canada
University of Copenhagen
Fudan University
Academia Sinica
University of British Columbia
Florida International University
University of Florida
University of Minnesota
New School